rosiglitazone has been researched along with triiodothyronine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 14 (77.78) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Endo, T; Kanda, T; Nakamura, H; Sakuma, S; Yamakawa, T; Yamasaki, S | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
| Gege, C; Hoffmann, T; Schlüter, T | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Arifi, S; Bischoff, I; Chaikuad, A; Fürst, R; Gellrich, L; Goebel, T; Heering, J; Heitel, P; Kahnt, A; Kilu, W; Knapp, S; Merk, D; Paulke, A; Pogoda, W; Pollinger, J; Proschak, E; Schubert-Zsilavecz, M; Steinhilber, D; Wurglics, M | 1 |
| Finley, E; Lee, HJ; Lee, SC; Soret, B; Vernon, RG | 1 |
| Bevilacqua, L; Gillespie, MA; Grenier, G; Harper, ME; Huh, MS; Rudnicki, MA; Scimè, A | 1 |
| Jatwa, R; Kar, A; Panda, S; Parmar, HS | 1 |
| Clerget-Froidevaux, MS; Decherf, S; Demeneix, B; Elgaaied, AB; Guissouma, H; Kouidhi, S; Seugnet, I | 1 |
| Blanchard, PG; Deshaies, Y; Festuccia, WT; Magdalon, J; Oliveira, TB; Paschoal, VA; Richard, D | 1 |
| Asano, H; Funaba, M; Higurashi, S; Kanamori, Y; Kato, K; Matsui, T; Nara, T | 1 |
| Beuers, U; Donkers, JM; IJzerman, AP; Kwakkenbos, MJ; Oude Elferink, RPJ; Urban, S; van de Graaf, SFJ; van Westen, GJP; Zehnder, B | 1 |
| Caporarello, N; Choi, KM; Haak, AJ; Jones, DL; Ligresti, G; Manlove, LJ; Meridew, JA; Prakash, YS; Tan, Q; Tschumperlin, DJ | 1 |
| Dai, W; Li, P; Liu, LY; Tu, JH; Wang, SX; Yang, XH; Yin, YL | 1 |
1 review(s) available for rosiglitazone and triiodothyronine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for rosiglitazone and triiodothyronine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Biological evaluation of novel benzisoxazole derivatives as PPARδ agonists.
Topics: Animals; Cell Differentiation; Cell Line; Cells, Cultured; Cerebral Cortex; Humans; Isoxazoles; Oligodendroglia; PPAR delta; Rats; Rats, Wistar | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.
Topics: Benzeneacetamides; Drug Inverse Agonism; Fluorescence Resonance Energy Transfer; Humans; Ligands; Nuclear Receptor Subfamily 1, Group F, Member 2; Nuclear Receptor Subfamily 1, Group F, Member 3; Protein Binding; Th17 Cells; Thiazoles; Tretinoin | 2014 |
l-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ.
Topics: Amino Acid Sequence; Animals; Drug Evaluation, Preclinical; Male; Mice; Models, Molecular; PPAR gamma; Protein Conformation; Thyroxine | 2020 |
Regulation of differentiation of sheep subcutaneous and abdominal preadipocytes in culture.
Topics: Abdomen; Adipose Tissue; Animals; Animals, Suckling; Cattle; Cell Differentiation; Cells, Cultured; Dexamethasone; Female; Fibroblast Growth Factors; Glucocorticoids; Growth Hormone; Insulin; Male; Pregnancy; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sheep; Thiazoles; Thiazolidinediones; Transcription Factors; Triiodothyronine | 1999 |
Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1alpha.
Topics: Adipocytes; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Cell Differentiation; Cells, Cultured; Ion Channels; Mice; Mice, Inbred BALB C; Mice, Knockout; Mitochondrial Proteins; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Promoter Regions, Genetic; Retinoblastoma Protein; Retinoblastoma-Like Protein p107; RNA; Rosiglitazone; Thiazolidinediones; Trans-Activators; Transcription Factors; Triiodothyronine; Uncoupling Protein 1 | 2005 |
Amelioration of corticosteroid-induced type 2 diabetes mellitus by rosiglitazone is possibly mediated through stimulation of thyroid function and inhibition of tissue lipid peroxidation in mice.
Topics: Animals; Blood Glucose; Catalase; Cholesterol; Dexamethasone; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glutathione; Hypoglycemic Agents; Insulin; Kidney; Lipid Peroxidation; Male; Mice; Myocardium; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones; Thyroxine; Triglycerides; Triiodothyronine | 2007 |
Peroxisome proliferator-activated receptor-gamma (PPARgamma) modulates hypothalamic Trh regulation in vivo.
Topics: Anilides; Animals; Animals, Newborn; Gene Expression Regulation; Gene Knockdown Techniques; Glucose Transporter Type 4; Hypothalamus; Injections, Intraventricular; Mice; Pioglitazone; PPAR gamma; Promoter Regions, Genetic; Retinoid X Receptor alpha; Rosiglitazone; Thiazolidinediones; Thyroid Hormone Receptors beta; Thyrotropin-Releasing Hormone; Thyroxine; Transfection; Triiodothyronine | 2010 |
PPARγ activation attenuates cold-induced upregulation of thyroid status and brown adipose tissue PGC-1α and D2.
Topics: Adipose Tissue, Brown; Animals; Cold Temperature; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Male; Models, Animal; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; RNA-Binding Proteins; Rosiglitazone; Signal Transduction; Thiazolidinediones; Thyroid Gland; Thyroxine; Time Factors; Transcription Factors; Triiodothyronine; Up-Regulation | 2012 |
Induction of beige-like adipocytes in 3T3-L1 cells.
Topics: 1-Methyl-3-isobutylxanthine; 3T3-L1 Cells; Adipocytes, White; Animals; Cell Differentiation; Ion Channels; Mice; Mitochondrial Proteins; Real-Time Polymerase Chain Reaction; RNA; Rosiglitazone; Thiazolidinediones; Transcription Factors; Triiodothyronine; Uncoupling Protein 1 | 2014 |
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.
Topics: Animals; Antiviral Agents; Dogs; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Humans; Indoles; Lipopeptides; Madin Darby Canine Kidney Cells; Organic Anion Transporters, Sodium-Dependent; Phenylcarbamates; Rosiglitazone; Sulfasalazine; Sulfonamides; Symporters; Tosyl Compounds; Triiodothyronine; Trypan Blue; Virus Internalization | 2017 |
PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state.
Topics: Actins; Animals; beta-Galactosidase; Bleomycin; Cell Line; Cellular Senescence; Collagen Type I; Collagen Type I, alpha 1 Chain; Cyclin-Dependent Kinase Inhibitor p16; Fibroblasts; Fibronectins; Gene Expression; Gene Knockdown Techniques; Humans; Hypoglycemic Agents; Idiopathic Pulmonary Fibrosis; Mice; Mitochondria; NAD; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Primary Cell Culture; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Triiodothyronine | 2019 |
Rosiglitazone via PPARγ-dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone.
Topics: Animals; Aorta, Thoracic; Blotting, Western; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Homocysteine; Human Umbilical Vein Endothelial Cells; Humans; Male; Microscopy, Fluorescence; NADPH Oxidases; NF-kappa B; Oxidative Stress; PPAR gamma; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Vasodilation | 2015 |